Axial Spondyloarthritis: Patient-Reported Impact in Europe

Axial Spondyloarthritis: Patient-Reported Impact in Europe

  • Marco Garrido-Cumbrera
  • Victoria Navarro-Compán
  • Christine Bundy
  • Raj Mahapatra
  • Souzi Makri
  • Carlos J. Delgado-Domínguez
  • Pedro Plazuelo-Ramos
  • Denis Poddubnyy
Publisher:Springer NatureISBN 13: 9783030976064ISBN 10: 3030976068

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks WagonGOBook ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books ₹0Audible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Axial Spondyloarthritis: Patient-Reported Impact in Europe is written by Marco Garrido-Cumbrera and published by Springer Nature. It's available with International Standard Book Number or ISBN identification 3030976068 (ISBN 10) and 9783030976064 (ISBN 13).

This open access book provides an overview of the International Map of Axial Spondyloarthritis (IMAS) project -focusing on Europe-, a wide-ranging, multi-disciplinary collaboration between academic groups, Health Care Professionals (HCPs), patient organizations and Novartis. IMAS was conceived to improve knowledge of Axial Spondyloarthritis (axSpA) and raise awareness of its heavy burden globally. By asking more than 2,000 patients across Europe about the impact of axSpA on multiple aspects of their life, the full extent of this disease was investigated from a direct patient perspective. This allowed a unique understanding of how living with axSpA affects the daily lives and well-being of patients, and how this varies between European countries. Axial Spondyloarthritis: Patient-Reported Impact in Europe highlights opportunities for progressing quality patient care to be applied to health services globally. HCPs, policy makers and patients will find this book to be an indispensable resource for improving the understanding of this chronic condition, including patients’ clinical outcomes, the protection of those at risk of psychological distress, and the economic burden on patients and society.